B Cells Enhance Antigen-Specific CD4 T Cell Priming and Prevent Bacteria Dissemination following Chlamydia muridarum Genital Tract Infection

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Li, Lin Xi ^a   McSorley, Stephen J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL COUNT; BACTERIAL DISSEMINATION; BACTERIAL LOAD; BACTERIAL PHENOMENA AND FUNCTIONS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CHLAMYDIASIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENITAL TRACT INFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HELA CELLS; HUMANS; IMMUNITY, CELLULAR; MALE; MICE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; REPRODUCTIVE TRACT INFECTIONS;

EID: 84887276576     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003707     Document Type: Article

References (42)

1. Starnbach MN, Roan NR, (2008) Conquering sexually transmitted diseases. Nature reviews Immunology 8: 313-317.
2. US Department of Health and Human Services (2012) Sexually Transmitted Disease Surveillance 2011. Available: http://www.cdc.gov/std/stats11/Surv2011.pdf.
3. Gottlieb SL, Berman SM, Low N, (2010) Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? The Journal of infectious diseases 201 Suppl 2: S156-167.
4. Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC, (2010) Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. The Journal of infectious diseases 201 Suppl 2: S190-204.
5. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, et al. (2010) Risk of sequelae after Chlamydia trachomatis genital infection in women. The Journal of infectious diseases 201 Suppl 2: S134-155.
6. Gottlieb SL, Brunham RC, Byrne GI, Martin DH, Xu F, et al. (2010) Introduction: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control. The Journal of infectious diseases 201 Suppl 2: S85-87.
7. Brunham RC, Rey-Ladino J, (2005) Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nature reviews Immunology 5: 149-161.
8. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI, (1997) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infection and immunity 65: 2145-2152.
9. Perry LL, Su H, Feilzer K, Messer R, Hughes S, et al. (1999) Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. Journal of immunology 162: 3541-3548.
10. Perry LL, Feilzer K, Caldwell HD, (1997) Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and-independent pathways. Journal of immunology 158: 3344-3352.
11. Cain TK, Rank RG, (1995) Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infection and immunity 63: 1784-1789.
12. Morrison RP, (2000) Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infection and immunity 68: 6038-6040.
13. Cohen CR, Koochesfahani KM, Meier AS, Shen C, Karunakaran K, et al. (2005) Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma. J Infect Dis 192: 591-599.
14. Cotter TW, Meng Q, Shen ZL, Zhang YX, Su H, et al. (1995) Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infection and immunity 63: 4704-4714.
15. Morrison SG, Su H, Caldwell HD, Morrison RP, (2000) Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infection and immunity 68: 6979-6987.
16. Morrison SG, Morrison RP, (2005) A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. Journal of immunology 175: 7536-7542.
17. Su H, Feilzer K, Caldwell HD, Morrison RP, (1997) Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infection and immunity 65: 1993-1999.
18. Ramsey KH, Soderberg LS, Rank RG, (1988) Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infection and immunity 56: 1320-1325.
19. Yang X, Brunham RC, (1998) Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. Journal of immunology 161: 1439-1446.
20. Brunham RC, Kuo C, Chen WJ, (1985) Systemic Chlamydia trachomatis infection in mice: a comparison of lymphogranuloma venereum and trachoma biovars. Infection and immunity 48: 78-82.
21. Karunakaran KP, Rey-Ladino J, Stoynov N, Berg K, Shen C, et al. (2008) Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. Journal of immunology 180: 2459-2465.
22. Moon JJ, Chu HH, Hataye J, Pagan AJ, Pepper M, et al. (2009) Tracking epitope-specific T cells. Nature protocols 4: 565-581.
23. Lee SJ, McLachlan JB, Kurtz JR, Fan D, Winter SE, et al. (2012) Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development. PLoS pathogens 8: e1002499.
24. Yu H, Jiang X, Shen C, Karunakaran KP, Jiang J, et al. (2010) Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Infection and immunity 78: 2272-2282.
25. Roan NR, Gierahn TM, Higgins DE, Starnbach MN, (2006) Monitoring the T cell response to genital tract infection. Proceedings of the National Academy of Sciences of the United States of America 103: 12069-12074.
26. McSorley SJ, Asch S, Costalonga M, Reinhardt RL, Jenkins MK, (2002) Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 16: 365-377.
27. Bold TD, Banaei N, Wolf AJ, Ernst JD, (2011) Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo. PLoS pathogens 7: e1002063.
28. Beatty WL, Byrne GI, Morrison RP, (1993) Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proceedings of the National Academy of Sciences of the United States of America 90: 3998-4002.
29. Johnson RM, Yu H, Kerr MS, Slaven JE, Karunakaran KP, et al. (2012) PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice. Infection and immunity 80: 2204-2211.
30. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, et al. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature immunology 10: 595-602.
31. Woolard MD, Hensley LL, Kawula TH, Frelinger JA, (2008) Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect Immun 76: 2651-2659.
32. Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, et al. (2010) Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nature immunology 11: 83-89.
33. Zhang Z, Clarke TB, Weiser JN, (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899-1909.
34. Morrison SG, Morrison RP, (2000) In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infection and immunity 68: 2870-2879.
35. Moseman EA, Iannacone M, Bosurgi L, Tonti E, Chevrier N, et al. (2012) B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity 36: 415-426.
36. Perry LL, Hughes S, (1999) Chlamydial colonization of multiple mucosae following infection by any mucosal route. Infection and immunity 67: 3686-3689.
37. Votte-Lambert A, Joly JP, Becuwe C, Eb F, Capron JP, et al. (1990) Chlamydia trachomatis peritonitis: another cause of protein-rich lymphocytic ascites. Journal of clinical gastroenterology 12: 341-343.
38. Wallace TM, Hart WR, (1991) Acute chlamydial salpingitis with ascites and adnexal mass simulating a malignant neoplasm. International journal of gynecological pathology: official journal of the International Society of Gynecological Pathologists 10: 394-401.
39. Guagenti RC, Berman AL, Cohen NN, (1989) Chlamydial ascites. Digestive diseases and sciences 34: 139-141.
40. Punnonen R, Terho P, Klemi PJ, (1982) Chlamydial pelvic inflammatory disease with ascites. Fertility and sterility 37: 270-272.
41. Scidmore MA, (2005) Cultivation and Laboratory Maintenance of Chlamydia trachomatis. Current protocols in microbiology Chapter 11: Unit 11A 11.
42. Yu H, Jiang X, Shen C, Karunakaran KP, Brunham RC, (2009) Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models. Journal of immunology 182: 1602-1608.